Efficacy And Safety Of Low Dose Tofacitinib As Induction Therapy In Moderate To Severe Ulcerative Colitis: A Pilot Study

Efficacy And Safety Of Low Dose Tofacitinib As Induction Therapy In Moderate To Severe Ulcerative Colitis: A Pilot Study

Objective: The Inflammatory cascade has been the root cause of ulcerative colitis's pathogenesis, and its treatment would centre upon reducing its intensity. Tofacitinib, an orally administered micromolecule, blocks the Janus kinase (JAK) signal transducer pathway, thereby reducing mucosal inf...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sadia Ahmed, Muhammad Umar, Muhammad Kamran, Misbah Noureen, Iqra Ashraf, Javeria Khan
Format:	Article
Language:	English
Published:	Rawalpindi Medical University 2024-12-01
Series:	Journal of Rawalpindi Medical College
Online Access:	https://www.journalrmc.com/index.php/JRMC/article/view/2421
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Colonic cytokines for severe ulcerative colitis
by: Ye. A. Konovich, et al.
Published: (2016-08-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Blood Lipid Levels and Their Value as Markers of Disease Activity in Severe Ulcerative Colitis
by: Zhu L, et al.
Published: (2025-02-01)

Comparison of scores for predictability of corticosteroid failure in patients with acute severe ulcerative colitis
by: Knežević Milica A., et al.
Published: (2024-01-01)

A Rare Cause of Severe Lower Gastrointestinal Bleeding in Ulcerative Colitis Patients in Remission: Giant Pseudopolyps
by: Ali Atay, et al.
Published: (2025-02-01)

Mesalazine use tactics in the ulcerative colitis patients
by: A. V. Korolev, et al.
Published: (2013-03-01)

Efficacy of mesalazine at ulcerative colitis with nutritional failure
by: A. V. Korolyov, et al.
Published: (2015-03-01)

Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative colitis–A preclinical systematic review and meta-analysis
by: Jinchen Chong, et al.
Published: (2025-02-01)

Serum cytokines in ulcerative colitis of various clinical activity
by: Ye. A. Konovich, et al.
Published: (2014-10-01)

Prevalence of Erosive-ulcerative Lesions of the Stomach and Helicobacter Pylori Infection in Patients with Ulcerative Colitis
by: N. A. Ponkratova, et al.
Published: (2019-06-01)

{'en_US': 'Correlation of Serum Alpha-Fetoprotein (AFP) Levels with the size of Hepatocellular carcinoma on Triphasic CT scan: A study in patients with the heterotrophic viral infection'}
by: Javeria Khan , Maria Khaliq , Tayyub Saeed , Muhammad Imran , Nasir Majeed , Rabia Khan , Muhammad Umar , Bushra Khaar , Tanveer Hussain , Sadia Ahmed , Misbah Noureen , Saima Ambreen Javeria Khan , Maria Khaliq , Tayyub Saeed , Muhammad Imran , Nasir Majeed , Rabia Khan , Muhammad Umar , Bushra Khaar , Tanveer Hussain , Sadia Ahmed , Misbah Noureen , Saima Ambreen
Published: (2023-01-01)

Colonic growth factors (G-CSF, GM-CSF) and chemokines (MCP-1, MIP-1β) in severe ulcerative colitis
by: Yevgeny A. Konovich, et al.
Published: (2018-08-01)

Results of formation of primary and secondary smallintestinal reservoirs at ulcerative colitis
by: V. N. Kashnikov, et al.
Published: (2014-12-01)

Can anticytokine therapy prevent unfavourable course of ulcerative colitis?
by: A. Yu. Baranovsky, et al.
Published: (2013-12-01)

Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
by: A. Yu. Baranovsky, et al.
Published: (2012-06-01)

Unraveling the microbial mysteries: gut microbiota’s role in ulcerative colitis
by: Keyu Ren, et al.
Published: (2025-02-01)

Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
by: Yu. P. Uspenskiy, et al.
Published: (2022-03-01)

Ulcerative colitis: STRIDE-ing beyond symptoms with new standards
by: Shu Wen Tay, et al.
Published: (2024-02-01)

Epidemiological and Clinical Aspects of Ulcerative Colitis in Mosul city, Iraq
by: Muhammed Babakir-Mina
Published: (2019-08-01)

Application of morphological criteria for definition of management approach for child with ulcerative colitis
by: E. N. Fedulova, et al.
Published: (2012-07-01)

Features of development and progression of colorectal cancer on a background of ulcerative colitis
by: I. L. Khalif, et al.
Published: (2012-02-01)

Metabolite profiling in assessing ulcerative colitis activity: A systematic review
by: Danyang Cui, et al.
Published: (2025-03-01)

Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis
by: Ada Corrado, et al.
Published: (2025-01-01)

Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
by: Cao R, et al.
Published: (2025-02-01)

Health benefits of algae and marine-derived bioactive metabolites for modulating ulcerative colitis symptoms
by: Najmeh Oliyaei, et al.
Published: (2025-02-01)

Effect of fecal microbiota transplantation on ulcerative colitis model in rats: The gut–brain axis
by: Mahdis Morshedbak, et al.
Published: (2025-02-01)

Guidelines of the Russian gastroenterological association and Russian Association of Coloproctology on diagnostics and treatment of ulcerative colitis in adults
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Correlation between fecal biomarkers and the presence of antineutrophil cytoplasmic antibodies with ulcerative colitis disease activity
by: Büşra Usta, et al.
Published: (2025-01-01)

Role of Aging in Ulcerative Colitis Pathogenesis: A Focus on ETS1 as a Promising Biomarker
by: Ni M, et al.
Published: (2025-02-01)

Identification of the immune infiltration and biomarkers in ulcerative colitis based on liquid–liquid phase separation-related genes
by: Zhixing Hong, et al.
Published: (2025-02-01)

Case Report: Combined Autoimmune Pancreatitis, Ulcerative Colitis and Sclerosing Cholangitis in 28-y.o. Patient
by: A. R. Khurmatullina, et al.
Published: (2025-02-01)

Integrated treatment of depression and moderate to severe alcohol use disorder in women shows promise in routine alcohol use disorder care – a pilot study
by: Anna Persson, et al.
Published: (2025-02-01)

Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn’s Disease
by: Sue Perera, et al.
Published: (2018-09-01)

C9orf72 Alleviates DSS‑Induced Ulcerative Colitis via the cGAS‐STING Pathway
by: Yue Wang, et al.
Published: (2025-01-01)

Disutility Study for Adult Patients with Moderate to Severe Crohn’s Disease
by: Melany Worbes-Cerezo, et al.
Published: (2019-03-01)

Short-term results of ileal pouch anastomosis in early and late terms after urgent surgery for complicated ulcerative colitis
by: Yu. E. Kitsenko, et al.
Published: (2018-08-01)

The short-term and long-term results of three-stage surgical treatment of ulcerative colitis with formation of ileal J-pouch
by: P. V. Tsarkov, et al.
Published: (2016-08-01)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
by: Peter C. Taylor, et al.
Published: (2022-07-01)

Adapting to ulcerative colitis to try to live a ‘normal’ life: a qualitative study of patients’ experiences in the Midlands region of England
by: Rachel Cooney, et al.
Published: (2017-08-01)